Found: 9
Select item for more details and to access through your institution.
Hémophilie A acquise, le traitement par emicizumab peut relayer les agents by-passants : à propos de deux cas et une revue de la littérature.
- Published in:
- Annales de Biologie Clinique, 2024, v. 82, n. 3, p. 294, doi. 10.1684/abc.2024.1900
- By:
- Publication type:
- Article
Long‐term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2233, doi. 10.1111/bjh.19409
- By:
- Publication type:
- Article
Autoimmune haemolytic anaemia associated with COVID‐19 infection.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 1, p. 29, doi. 10.1111/bjh.16794
- By:
- Publication type:
- Article
Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 146, doi. 10.1111/bjh.15718
- By:
- Publication type:
- Article
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization ( FILO).
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 439, doi. 10.1111/bjh.14881
- By:
- Publication type:
- Article
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E353, doi. 10.1002/ajh.26274
- By:
- Publication type:
- Article
Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. E183, doi. 10.1002/ajh.25480
- By:
- Publication type:
- Article
KMT2A-ARHGEF12, a therapy related fusion with poor prognosis.
- Published in:
- Molecular Biology Reports, 2021, v. 48, n. 10, p. 7021, doi. 10.1007/s11033-021-06621-5
- By:
- Publication type:
- Article
Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature review.
- Published in:
- EJHaem, 2020, v. 1, n. 2, p. 601, doi. 10.1002/jha2.80
- By:
- Publication type:
- Article